Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1978) 1978
Book Chapter (60) 60
Conference Proceeding (4) 4
Dissertation (4) 4
Magazine Article (4) 4
Publication (2) 2
Web Resource (2) 2
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
pegylated interferon (1089) 1089
science & technology (1067) 1067
life sciences & biomedicine (1056) 1056
humans (1027) 1027
ribavirin (875) 875
male (636) 636
antiviral agents - therapeutic use (632) 632
hepatitis c (619) 619
female (599) 599
hepatitis c, chronic - drug therapy (547) 547
interferon-alpha - therapeutic use (525) 525
middle aged (521) 521
adult (501) 501
hepatitis c virus (480) 480
interferon (460) 460
treatment outcome (456) 456
gastroenterology & hepatology (449) 449
polyethylene glycols - therapeutic use (412) 412
drug therapy, combination (405) 405
ribavirin - therapeutic use (397) 397
chronic hepatitis c (375) 375
recombinant proteins (365) 365
infectious diseases (334) 334
biological response modifiers (318) 318
genotype (286) 286
hepacivirus - genetics (279) 279
biological and medical sciences (270) 270
medical sciences (266) 266
aged (264) 264
antiviral agents - adverse effects (240) 240
interferon-alpha - administration & dosage (239) 239
antiviral agents - administration & dosage (225) 225
interferon-alpha - adverse effects (223) 223
hepatitis (201) 201
recombinant proteins - therapeutic use (201) 201
polyethylene glycols - administration & dosage (196) 196
viral hepatitis (195) 195
hepatitis c, chronic - virology (188) 188
viral diseases (184) 184
ribavirin - administration & dosage (182) 182
care and treatment (181) 181
human viral diseases (180) 180
antiviral agents (177) 177
health aspects (177) 177
hepatitis c - drug therapy (170) 170
polyethylene glycols - adverse effects (170) 170
viral load (162) 162
virology (162) 162
hepacivirus - drug effects (156) 156
pharmacology & pharmacy (155) 155
rna, viral - blood (153) 153
virus diseases (152) 152
ribavirin - adverse effects (143) 143
pharmacology. drug treatments (139) 139
analysis (135) 135
drug therapy (134) 134
retrospective studies (121) 121
chronic hepatitis b (119) 119
hepatitis c, chronic - complications (118) 118
gastroenterology and hepatology (113) 113
hepatitis b (113) 113
oncology (111) 111
hcv (109) 109
young adult (108) 108
hepatitis b, chronic - drug therapy (107) 107
hepatology (107) 107
digestive system diseases (106) 106
polyethylene glycols (106) 106
sustained virological response (106) 106
medicine & public health (105) 105
time factors (105) 105
treatment (103) 103
hiv (98) 98
prospective studies (97) 97
antibiotics. antiinfectious agents. antiparasitic agents (95) 95
risk factors (95) 95
genetic aspects (93) 93
cirrhosis (91) 91
medicine, general & internal (91) 91
general & internal medicine (89) 89
recombinant proteins - administration & dosage (89) 89
adolescent (86) 86
interferon alpha (86) 86
telaprevir (83) 83
gastroenterology. liver. pancreas. abdomen (81) 81
hepatitis b virus (81) 81
interferon alpha-2 (80) 80
research (80) 80
recombinant proteins - adverse effects (78) 78
pegylated-interferon (77) 77
liver (76) 76
hepatocellular carcinoma (75) 75
immunology (75) 75
recurrence (74) 74
animals (73) 73
liver cirrhosis (71) 71
hiv infections - complications (69) 69
hepacivirus - isolation & purification (68) 68
hepatitis c, chronic - diagnosis (67) 67
liver transplantation (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1797) 1797
Korean (74) 74
Japanese (46) 46
Spanish (35) 35
Hungarian (23) 23
Portuguese (23) 23
Czech (22) 22
German (22) 22
French (21) 21
Polish (15) 15
Russian (12) 12
Turkish (6) 6
Chinese (4) 4
Slovak (4) 4
Serbian (2) 2
Croatian (1) 1
Italian (1) 1
Persian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
by Suppiah, Vijayaprakash and Moldovan, Max and Ahlenstiel, Golo and Berg, Thomas and Weltman, Martin and Abate, Maria Lorena and Bassendine, Margaret and Spengler, Ulrich and Dore, Gregory J and Powell, Elizabeth and Riordan, Stephen and Sheridan, David and Smedile, Antonina and Fragomeli, Vincenzo and Müller, Tobias and Bahlo, Melanie and Stewart, Graeme J and Booth, David R and George, Jacob and Hepatitis C Study and for the Hepatitis C Study
Nature genetics, ISSN 1061-4036, 10/2009, Volume 41, Issue 10, pp. 1100 - 1104
Life Sciences & Biomedicine | Genetics & Heredity | Science & Technology | Fundamental and applied biological sciences. Psychology | Viral hepatitis | Infectious diseases | Viral diseases | Biological and medical sciences | Genetics of eukaryotes. Biological and molecular evolution | Medical sciences | Human viral diseases | Genome-Wide Association Study | Antiviral Agents - therapeutic use | Humans | Middle Aged | Ribavirin - therapeutic use | Gene Expression Regulation | Interferon-alpha - therapeutic use | Hepatitis C, Chronic - virology | Genotype | Male | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Polyethylene Glycols - therapeutic use | Interleukins - genetics | Adult | Female | Polymorphism, Single Nucleotide | Australia | Drug Therapy, Combination | Hepatitis C, Chronic - genetics | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Interferon-λpolymorphisms and response to pegylated interferon in Iranian hepatitis C patients
by Haj-sheykholeslami, Arghavan and Keshvari, Maryam and Sharafi, Heidar and Pouryasin, Ali and Hemmati, Khalil and Mohammadzadehparjikolaei, Fatemeh
World journal of gastroenterology : WJG, ISSN 1007-9327, 08/2015, Volume 21, Issue 29, pp. 8848 - 8857
Sustained virologic response? | Rs8099917 | Rs12979860 | Chronic hepatitis C | Pegylated interferon | Recombinant Proteins - therapeutic use | Multivariate Analysis | Prospective Studies | Humans | Middle Aged | Hepacivirus - genetics | Male | RNA, Viral - blood | Polyethylene Glycols - therapeutic use | Viral Load | Interleukins - genetics | Iran | Adult | Female | Drug Therapy, Combination | Odds Ratio | Hepacivirus - drug effects | Pharmacogenetics | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Interferon-alpha - therapeutic use | Genotype | Logistic Models | Treatment Outcome | Hepatitis C, Chronic - diagnosis | Hepatitis C, Chronic - drug therapy | Phenotype | Hepatitis C, Chronic - immunology | Polymorphism, Single Nucleotide | Hepatitis C, Chronic - genetics | Index Medicus | Prospective Study | rs12979860 | rs8099917 | Sustained virologic response
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text HCV direct‐acting antiviral agents: the best interferon‐free combinations
by Schinazi, Raymond and Halfon, Philippe and Marcellin, Patrick and Asselah, Tarik
Liver international, ISSN 1478-3223, 02/2014, Volume 34, Issue 1, pp. 69 - 78
sofosbuvir | faldaprevir | ribavirin | simeprevir | pegylated interferon | asunaprevir | daclatasvir | Daclatasvir | Simeprevir | Pegylated interferon | Faldaprevir | Asunaprevir | Ribavirin | Sofosbuvir | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Heterocyclic Compounds, 3-Ring | Hepatitis C - drug therapy | Oligopeptides | Isoquinolines | Humans | Hepacivirus - genetics | Drug Discovery - methods | Disease Eradication - methods | Recombinant Proteins | Protease Inhibitors - pharmacology | Thiazoles | Hepacivirus - drug effects | Virus Replication - drug effects | Antiviral Agents - pharmacology | Polyethylene Glycols | Antiviral Agents - therapeutic use | Interferon-alpha | Clinical Trials as Topic | Disease Eradication - trends | Drug Therapy, Combination - methods | Drug Therapy, Combination - trends | Imidazoles | Sulfonamides | Uridine Monophosphate - analogs & derivatives | Viral Nonstructural Proteins - antagonists & inhibitors | Virus Replication - physiology | Hepatitis C virus | Biological response modifiers | Interferon | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Anti‐interferon‐α neutralizing antibody is associated with nonresponse to pegylated interferon‐α plus ribavirin in chronic hepatitis C
by Matsuda, F and Torii, Y and Enomoto, H and Kuga, C and Aizawa, N and Iwata, Y and Saito, M and Imanishi, H and Shimomura, S and Nakamura, H and Tanaka, H and Iijima, H and Tsutsui, H and Tanaka, Y and Nishiguchi, S
Journal of viral hepatitis, ISSN 1352-0504, 10/2012, Volume 19, Issue 10, pp. 694 - 703
anti‐interferon‐α neutralizing antibody | nonresponse | natural interferon‐β | chronic hepatitis C | pegylated interferon‐α | pegylated interferon-α | anti-interferon-α neutralizing antibody | natural interferon-β | Humans | Middle Aged | Male | Neutralization Tests | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Interferon-alpha - immunology | Interferon-alpha - administration & dosage | Ribavirin - administration & dosage | Adult | Female | Aged | Antibodies, Neutralizing - blood | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Systematic review of acute pancreatitis associated with interferon-α or pegylated interferon-α: Possible or definitive causation?
by Bazerbachi, Fateh and Haffar, Samir and Hussain, Mohammad Tahir and Vargas, Eric J and Watt, Kymberly D and Murad, M. Hassan and Chari, Suresh and Abu Dayyeh, Barham K
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], ISSN 1424-3903, 10/2018, Volume 18, Issue 7, pp. 691 - 699
Human | Systematic review | Acute pancreatitis | Interferon-alpha | Pegylated interferon-alpha | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Acute Disease | Interferon-alpha - adverse effects | Pancreatitis - chemically induced | Humans | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Efficacy and Safety of Pegylated Interferon for the Treatment of Chronic Hepatitis B in Children and Adolescents: A Systematic Review and Meta-analysis
by He, Yi and Yin, Jingyang and Xu, Hongmei
The Pediatric infectious disease journal, ISSN 0891-3668, 12/2020, Volume 39, Issue 12, pp. 1121 - 1126
chronic hepatitis B | meta-analysis | pegylated interferon | children | Pediatrics | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Medical colleges | Medical research | Analysis | Medicine, Experimental | Development and progression | Interferon | Biological response modifiers | Drug therapy | Hepatitis B | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Pegylated interferon alpha – 2a is clinically effective and tolerable in myeloproliferative neoplasm patients treated off clinical trial
by Gowin, K and Jain, T and Kosiorek, H and Tibes, R and Camoriano, J and Palmer, J and Mesa, R
Leukemia research, ISSN 0145-2126, 2017, Volume 54, pp. 73 - 77
Hematology, Oncology and Palliative Medicine | Polycythemia vera | Myelofibrosis | Pegylated interferon | Myeloproliferative neoplasms | Essential thrombocytosis | Oncology | Life Sciences & Biomedicine | Hematology | Science & Technology | Recombinant Proteins - therapeutic use | Thrombocythemia, Essential - drug therapy | Primary Myelofibrosis - drug therapy | Humans | Middle Aged | Interferon-alpha - therapeutic use | Polyethylene Glycols - adverse effects | Male | Treatment Outcome | Fatigue - chemically induced | Myeloproliferative Disorders - drug therapy | Recombinant Proteins - adverse effects | Polyethylene Glycols - therapeutic use | Leukopenia - chemically induced | Adult | Polycythemia Vera - drug therapy | Aged | Bone Marrow Neoplasms - drug therapy | Interferon-alpha - adverse effects | Myeloproliferative Disorders - complications | Retrospective Studies | Clinical trials | Biological response modifiers | Interferon alpha | Tumors | Medical colleges | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Sarcoidosis induced by interferon-α in melanoma patients: Incidence, clinical manifestations, and management strategies
by Heinzerling, Lucie M and Anliker, Mark D and Müller, Joachim and Schlaeppi, Marc and Von Moos, Roger
Journal of immunotherapy (1997), ISSN 1524-9557, 10/2010, Volume 33, Issue 8, pp. 834 - 839
pegylated interferon | drug reaction | response | Morbus Boeck | granuloma | Oncology | Immunology | Life Sciences & Biomedicine | Medicine, Research & Experimental | Science & Technology | Research & Experimental Medicine | Tumors of the skin and soft tissue. Premalignant lesions | Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis | Dermatology | Immunotherapy | Pharmacology. Drug treatments | Biological and medical sciences | Medical sciences | Antineoplastic agents | Melanoma - epidemiology | Granuloma | Melanoma - complications | Sarcoidosis - diagnosis | Diagnosis, Differential | Melanoma - diagnosis | Humans | Middle Aged | Male | Sarcoidosis - etiology | Withholding Treatment | Disease Progression | Incidence | Interferon-alpha - administration & dosage | Sarcoidosis - epidemiology | Neoplasm Metastasis | Hepatitis C - epidemiology | Melanoma - drug therapy | Sarcoidosis - physiopathology | Interferon-alpha - adverse effects | Retrospective Studies | Melanoma - physiopathology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Impaired induction of interleukin 28B and expression of interferon λ 4 associated with nonresponse to interferon‐based therapy in chronic hepatitis C
by Murakawa, Miyako and Asahina, Yasuhiro and Nakagawa, Mina and Sakamoto, Naoya and Nitta, Sayuri and Kusano‐Kitazume, Akiko and Watanabe, Takako and Kawai‐Kitahata, Fukiko and Otani, Satoshi and Taniguchi, Miki and Goto, Fumio and Nishimura‐Sakurai, Yuki and Itsui, Yasuhiro and Azuma, Seishin and Kakinuma, Sei and Watanabe, Mamoru
Journal of gastroenterology and hepatology, ISSN 0815-9319, 06/2015, Volume 30, Issue 6, pp. 1075 - 1084
peripheral blood mononuclear cells | hepatitis C virus | pegylated interferon | type III interferon | NS3 protease inhibitor | Peripheral blood mononuclear cells | Type III interferon | Hepatitis C virus | Pegylated interferon | Gene Expression - genetics | Humans | Middle Aged | Interferon-alpha - therapeutic use | Male | Hepatitis C, Chronic - drug therapy | Drug Resistance - genetics | Interleukins - genetics | Interleukins - physiology | Alleles | Adult | Female | Aged | Polymorphism, Single Nucleotide | Interleukins - biosynthesis | Hepatitis C, Chronic - genetics | RNA, Messenger | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text IL‐28β gene polymorphism determines virological response to PEGylated interferon therapy in hepatitis C virus genotype 4 Egyptian patients
by El‐Khazragy, Nashwa and El Sayed, Naglaa and Salem, Ahmed M and Hassan, Nahla S and Abdelmoeaz, Amal Tohamy and Maher, Amany M and Mansy, Azza El‐Sayed
Journal of cellular biochemistry, ISSN 0730-2312, 05/2019, Volume 120, Issue 5, pp. 8154 - 8159
rs12979860 | IL28β gene polymorphism | PEGylated interferon/ribavirin | sustained virological response | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | Cell Biology | Therapy | Viruses | Gene polymorphism | Patients | Ribavirin | Polymerase chain reaction | Hepatitis | Genotype & phenotype | Interferon | Genetic factors | Hepatitis C virus | Hepatitis C | Genotypes | Polymorphism
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Interaction of PEGylated interferon-beta with antibodies to recombinant interferon-beta
by Gilli, Francesca and De La Torre, Adrianna L and Royce, Darlene B and Pachner, Andrew R
International immunopharmacology, ISSN 1567-5769, 09/2018, Volume 62, pp. 1 - 6
NABs | Multiple sclerosis | Plegridy | Interferonβ | PEGylated IFNβ | Neutralizing antibodies | Pharmacology & Pharmacy | Immunology | Life Sciences & Biomedicine | Science & Technology | A549 Cells | Interferon-beta - immunology | Multiple Sclerosis - blood | Polyethylene Glycols | Humans | Cytopathogenic Effect, Viral | Neutralization Tests | Encephalomyocarditis virus - immunology | Cross Reactions | Recombinant Proteins - immunology | Multiple Sclerosis - immunology | Biological Assay | Antibodies, Neutralizing - blood | Myxovirus Resistance Proteins - biosynthesis | Viral antibodies | Medical research | Medical colleges | Analysis | Interferon beta | Medicine, Experimental | Antibodies | Biological response modifiers | Formulations | Antigens | Immunoglobulins | Myxovirus resistance proteins | β-Interferon | Bias | Cross-reactivity | Assaying | Patients | Biological activity | Proteins | Interferon | In vivo methods and tests | Physicochemical properties | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights